Last 12 months
Inside the activity.
1 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 1 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 8 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2026 Filed Feb 25, 2026 19:57 UTC |
JOHNSON DAVID LEEChief Operating Officer
|
SaleClass A Common Stock | 2,579 | $41.98 | $108,276.48 |
DisclosureSEC source: 0001733883-26-000006 · form4-02262026_120221.xml · nonDerivative · entry 1 JOHNSON DAVID LEE · CIK 0001733883 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,727 F1 · date: The trading order for shares sold to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) of all participants for the Issuer, including the Reporting Person, occurred over a period of two (2) business days, beginning on February 23, 2026 and ending on February 24, 2026. F2 · kind: Shares sold to solely satisfy tax withholding obligations incurred upon vesting of restricted stock units. The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and does not represent a discretionary trade by the reporting person. F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.005 to $42.84, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 19:56 UTC |
Turner William D.Chief Regulatory Officer
|
SaleClass A Common Stock | 2,187 | $41.98 | $91,818.79 |
DisclosureSEC source: 0001819688-26-000005 · form4-02262026_120218.xml · nonDerivative · entry 1 Turner William D. · CIK 0001819688 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,313 F1 · date: The trading order for shares sold to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) of all participants for the Issuer, including the Reporting Person, occurred over a period of two (2) business days, beginning on February 23, 2026 and ending on February 24, 2026. F2 · kind: Shares sold to solely satisfy tax withholding obligations incurred upon vesting of restricted stock units. The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and does not represent a discretionary trade by the reporting person. F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.005 to $42.84, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 23, 2026 Filed Feb 26, 2026 00:59 UTC |
Grant SeanCHIEF FINANCIAL OFFICER
|
SaleClass A Common Stock | 4,949 | $41.98 | $207,778.32 |
DisclosureSEC source: 0001872792-26-000004 · form4-02262026_120222.xml · nonDerivative · entry 1 Grant Sean · CIK 0001872792 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,181 F1 · date: The trading order for shares sold to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) of all participants for the Issuer, including the Reporting Person, occurred over a period of two (2) business days, beginning on February 23, 2026 and ending on February 24, 2026. F2 · kind: Shares sold to solely satisfy tax withholding obligations incurred upon vesting of restricted stock units. The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and does not represent a discretionary trade by the reporting person. F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.005 to $42.84, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 23, 2026 Filed Feb 26, 2026 00:58 UTC |
Fordyce MarshallDirector · PRESIDENT AND CEO
|
SaleClass A Common Stock | 16,925 | $41.98 | $710,577.51 |
DisclosureSEC source: 0001859453-26-000004 · form4-02262026_120224.xml · nonDerivative · entry 1 Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,163 F1 · date: The trading order for shares sold to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) of all participants for the Issuer, including the Reporting Person, occurred over a period of two (2) business days, beginning on February 23, 2026 and ending on February 24, 2026. F2 · kind: Shares sold to solely satisfy tax withholding obligations incurred upon vesting of restricted stock units. The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and does not represent a discretionary trade by the reporting person. F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.005 to $42.84, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 23, 2026 Filed Feb 26, 2026 00:53 UTC |
Skelton Laurence MatthewChief Commercial Officer
|
SaleClass A Common Stock | 1,582 | $41.98 | $66,418.53 |
DisclosureSEC source: 0002108080-26-000004 · form4-02262026_120224.xml · nonDerivative · entry 1 Skelton Laurence Matthew · CIK 0002108080 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,218 F1 · date: The trading order for shares sold to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) of all participants for the Issuer, including the Reporting Person, occurred over a period of two (2) business days, beginning on February 23, 2026 and ending on February 24, 2026. F2 · kind: Shares sold to solely satisfy tax withholding obligations incurred upon vesting of restricted stock units. The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell-to-cover" transaction and does not represent a discretionary trade by the reporting person. F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.005 to $42.84, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 20:00 UTC |
Brenner RobertChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $42.74 | $0.00 |
DisclosureSEC source: 0002006910-26-000002 · form4-02062026_080201.xml · derivative · entry 2 Brenner Robert · CIK 0002006910 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2036-02-03 F3 · derivative.exercise_date: 1/48th of the shares subject to the stock option will vest and become exercisable on March 4, 2026, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 20:00 UTC |
Brenner RobertChief Medical Officer
|
GrantClass A Common Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002006910-26-000002 · form4-02062026_080201.xml · nonDerivative · entry 1 Brenner Robert · CIK 0002006910 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,098 F1 · shares: Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") granted under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of February 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date. F2 · balance_after: Includes 624 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on March 13, 2025. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 20:00 UTC |
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $42.74 | $0.00 |
DisclosureSEC source: 0001861684-26-000002 · form4-02062026_080213.xml · derivative · entry 2 Young Joseph R · CIK 0001861684 · SVP, FINANCE, CHIEF ACCT OFFCR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Class A Common Stock · 20,000 shares Expires 2036-02-03 F2 · derivative.exercise_date: 1/48th of the shares subject to the stock option will vest and become exercisable on March 4, 2026, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 20:00 UTC |
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR
|
GrantClass A Common Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001861684-26-000002 · form4-02062026_080213.xml · nonDerivative · entry 1 Young Joseph R · CIK 0001861684 · SVP, FINANCE, CHIEF ACCT OFFCR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,839 F1 · shares: Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") granted under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of February 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 20:00 UTC |
JOHNSON DAVID LEEChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $42.74 | $0.00 |
DisclosureSEC source: 0001733883-26-000002 · form4-02062026_080203.xml · derivative · entry 2 JOHNSON DAVID LEE · CIK 0001733883 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Class A Common Stock · 40,000 shares Expires 2036-02-03 F3 · derivative.exercise_date: 1/48th of the shares subject to the stock option will vest and become exercisable on March 4, 2026, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 20:00 UTC |
JOHNSON DAVID LEEChief Operating Officer
|
GrantClass A Common Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001733883-26-000002 · form4-02062026_080203.xml · nonDerivative · entry 1 JOHNSON DAVID LEE · CIK 0001733883 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,306 F1 · shares: Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") granted under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of February 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date. F2 · balance_after: Includes 643 shares of Class A Common Stock acquired on March 13, 2025 and 763 shares of Class A Common Stock acquired on September 12, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 20:00 UTC |
Turner William D.Chief Regulatory Officer
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $42.74 | $0.00 |
DisclosureSEC source: 0001819688-26-000002 · form4-02062026_080205.xml · derivative · entry 2 Turner William D. · CIK 0001819688 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2036-02-03 F2 · derivative.exercise_date: 1/48th of the shares subject to the stock option will vest and become exercisable on March 4, 2026, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 20:00 UTC |
Turner William D.Chief Regulatory Officer
|
GrantClass A Common Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001819688-26-000002 · form4-02062026_080205.xml · nonDerivative · entry 1 Turner William D. · CIK 0001819688 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,500 F1 · shares: Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") granted under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of February 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 04, 2026 Filed Feb 7, 2026 01:00 UTC |
Fordyce MarshallDirector · PRESIDENT AND CEO
|
GrantStock Option (right to buy) · Derivative | 137,500 | $0.00 Strike: $42.74 | $0.00 |
DisclosureSEC source: 0001859453-26-000002 · form4-02062026_080211.xml · derivative · entry 4 Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,500 Underlying: Class A Common Stock · 137,500 shares Expires 2036-02-03 F4 · derivative.exercise_date: 1/48th of the shares subject to the stock option will vest and become exercisable on March 4, 2026, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 04, 2026 Filed Feb 7, 2026 01:00 UTC |
Fordyce MarshallDirector · PRESIDENT AND CEO
|
GrantClass A Common Stock | 68,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001859453-26-000002 · form4-02062026_080211.xml · nonDerivative · entry 1 Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,088 F1 · shares: Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") granted under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of February 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date. F2 · balance_after: Includes 623 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on March 13, 2025. Read SEC document |
| February 04, 2026 Filed Feb 7, 2026 01:00 UTC |
Grant SeanCHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $42.74 | $0.00 |
DisclosureSEC source: 0001872792-26-000002 · form4-02062026_080209.xml · derivative · entry 3 Grant Sean · CIK 0001872792 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Class A Common Stock · 50,000 shares Expires 2036-02-03 F3 · derivative.exercise_date: 1/48th of the shares subject to the stock option will vest and become exercisable on March 4, 2026, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 04, 2026 Filed Feb 7, 2026 01:00 UTC |
Grant SeanCHIEF FINANCIAL OFFICER
|
GrantClass A Common Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001872792-26-000002 · form4-02062026_080209.xml · nonDerivative · entry 1 Grant Sean · CIK 0001872792 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,130 F1 · shares: Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") granted under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of February 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date. F2 · balance_after: Includes 893 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on September 12, 2025. Read SEC document |
| February 04, 2026 Filed Feb 7, 2026 01:00 UTC |
Skelton Laurence MatthewChief Commercial Officer
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $42.74 | $0.00 |
DisclosureSEC source: 0002108080-26-000002 · form4-02062026_080207.xml · derivative · entry 2 Skelton Laurence Matthew · CIK 0002108080 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Class A Common Stock · 40,000 shares Expires 2036-02-03 F2 · derivative.exercise_date: 1/48th of the shares subject to the stock option will vest and become exercisable on March 4, 2026, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 04, 2026 Filed Feb 7, 2026 01:00 UTC |
Skelton Laurence MatthewChief Commercial Officer
|
GrantClass A Common Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002108080-26-000002 · form4-02062026_080207.xml · nonDerivative · entry 1 Skelton Laurence Matthew · CIK 0002108080 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,800 F1 · shares: Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") granted under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of February 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:05 UTC |
Turner William D.Chief Regulatory Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $15.53 | $0.00 |
DisclosureSEC source: 0001193125-25-322691 · ownership.xml · derivative · entry 3 Turner William D. · CIK 0001819688 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 245,000 Underlying: Class A Common Stock · 10,000 shares Expires 2034-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the option vested on January 5, 2025, and 1/48 of the shares vest monthly thereafter, subject to continuous service of the Reporting Person through each vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:05 UTC |
Turner William D.Chief Regulatory Officer
|
SaleClass A Common Stock | 10,000 | $50.08 | $500,767.00 |
DisclosureSEC source: 0001193125-25-322691 · ownership.xml · nonDerivative · entry 2 Turner William D. · CIK 0001819688 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $50.00 to $50.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:05 UTC |
Turner William D.Chief Regulatory Officer
|
Exercise / conversionClass A Common Stock | 10,000 | $15.53 | $155,300.00 |
DisclosureSEC source: 0001193125-25-322691 · ownership.xml · nonDerivative · entry 1 Turner William D. · CIK 0001819688 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2025 Filed Dec 16, 2025 01:07 UTC |
ENRIGHT PATRICK GDirector
|
PurchaseClass A Common Stock | 5,882 | $42.50 | $249,985.00 |
DisclosureSEC source: 0001193125-25-319649 · ownership.xml · nonDerivative · entry 1 ENRIGHT PATRICK G · CIK 0001253886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,882 Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 16:05 UTC |
Turner William D.Chief Regulatory Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $15.53 | $0.00 |
DisclosureSEC source: 0001193125-25-314156 · ownership.xml · derivative · entry 3 Turner William D. · CIK 0001819688 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 255,000 Underlying: Class A Common Stock · 10,000 shares Expires 2034-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the option vested on January 5, 2025, and 1/48 of the shares vest monthly thereafter, subject to continuous service of the Reporting Person through each vesting date. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 16:05 UTC |
Turner William D.Chief Regulatory Officer
|
SaleClass A Common Stock | 10,000 | $45.31 | $453,053.00 |
DisclosureSEC source: 0001193125-25-314156 · ownership.xml · nonDerivative · entry 2 Turner William D. · CIK 0001819688 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 16:05 UTC |
Turner William D.Chief Regulatory Officer
|
Exercise / conversionClass A Common Stock | 10,000 | $15.53 | $155,300.00 |
DisclosureSEC source: 0001193125-25-314156 · ownership.xml · nonDerivative · entry 1 Turner William D. · CIK 0001819688 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 16:05 UTC |
Turner William D.Chief Regulatory Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $15.53 | $0.00 |
DisclosureSEC source: 0001193125-25-308074 · ownership.xml · derivative · entry 3 Turner William D. · CIK 0001819688 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 265,000 Underlying: Class A Common Stock · 10,000 shares Expires 2034-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the option vested on January 5, 2025, and 1/48 of the shares vest monthly thereafter, subject to continuous service of the Reporting Person through each vesting date. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 16:05 UTC |
Turner William D.Chief Regulatory Officer
|
SaleClass A Common Stock | 10,000 | $40.00 | $400,000.00 |
DisclosureSEC source: 0001193125-25-308074 · ownership.xml · nonDerivative · entry 2 Turner William D. · CIK 0001819688 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025. Read SEC document |
| December 03, 2025 Filed Dec 4, 2025 16:05 UTC |
Turner William D.Chief Regulatory Officer
|
Exercise / conversionClass A Common Stock | 10,000 | $15.53 | $155,300.00 |
DisclosureSEC source: 0001193125-25-308074 · ownership.xml · nonDerivative · entry 1 Turner William D. · CIK 0001819688 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 21:37 UTC |
Meyers James RDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $29.43 | $0.00 |
DisclosureSEC source: 0001193125-25-300677 · ownership.xml · derivative · entry 1 Meyers James R · CIK 0001387521 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires 2035-11-24 F1 · derivative.exercise_date: The shares subject to the stock option will vest monthly over a three-year period subject to the Reporting Person's continuous service on each vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 16:05 UTC |
Carter Jason SChief Legal Officer
|
SaleClass A Common Stock | 3,864 | $27.82 | $107,498.03 |
DisclosureSEC source: 0001193125-25-297161 · ownership.xml · nonDerivative · entry 1 Carter Jason S · CIK 0002045094 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,136 F1 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $27.19 to $28.035, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 13, 2025 Filed Nov 13, 2025 20:57 UTC |
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $3.94 | $0.00 |
DisclosureSEC source: 0001193125-25-280792 · ownership.xml · derivative · entry 3 Young Joseph R · CIK 0001861684 · SVP, FINANCE, CHIEF ACCT OFFCR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,589 Underlying: Class A Common Stock · 10,000 shares Expires 2031-04-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the option vest on March 9, 2022, and 1/48 of the shares vest monthly thereafter. Read SEC document |
| November 13, 2025 Filed Nov 13, 2025 20:57 UTC |
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR
|
Exercise / conversionClass A Common Stock | 10,000 | $3.94 | $39,396.00 |
DisclosureSEC source: 0001193125-25-280792 · ownership.xml · nonDerivative · entry 2 Young Joseph R · CIK 0001861684 · SVP, FINANCE, CHIEF ACCT OFFCR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 20:57 UTC |
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR
|
SaleClass A Common Stock | 15,000 | $29.06 | $435,874.50 |
DisclosureSEC source: 0001193125-25-280792 · ownership.xml · nonDerivative · entry 1 Young Joseph R · CIK 0001861684 · SVP, FINANCE, CHIEF ACCT OFFCR 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,839 F1 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $29.03 to $29.17, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: Includes 893 ordinary shares acquired pursuant to the Company's 2021 Employee Stock Purchase Plan. Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 00:07 UTC |
ENRIGHT PATRICK GDirector
|
PurchaseClass A Common Stock | 27,071 | $22.35 | $605,082.87 |
DisclosureSEC source: 0000950170-25-090110 · ownership.xml · nonDerivative · entry 4 ENRIGHT PATRICK G · CIK 0001253886 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 3,596,593 F4 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $21.67 to $22.50, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote 4 to this Form 4. F3 · ownership.nature: These shares are held by Longitude Venture Partners IV, L.P ("LVPIV"). Longitude Capital Partners IV, LLC ("LCPIV") is the general partner of LVPIV and may be deemed to have voting and dispositive power over the shares held by LVPIV. The Reporting Person and Ms. Tammenoms Bakker are managing members of LCPIV and may be deemed to share voting and dispositive power with respect to the shares held by LVPIV. Each of LCPIV, the Reporting Person and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 00:07 UTC |
ENRIGHT PATRICK GDirector
|
PurchaseClass A Common Stock | 13,536 | $22.35 | $302,552.61 |
DisclosureSEC source: 0000950170-25-090110 · ownership.xml · nonDerivative · entry 3 ENRIGHT PATRICK G · CIK 0001253886 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,797,619 F4 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $21.67 to $22.50, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote 4 to this Form 4. F2 · ownership.nature: These shares are held by Longitude Prime Fund, L.P. ("LPF"). Longitude Prime Partners, LLC ("LPP") is the general partner of LPF and may be deemed to have voting and investment power over the securities held by LPF. The Reporting Person and Juliet Tammenoms Bakker are the managing members of LPP and may be deemed to share voting and dispositive power over the shares held by LPF. Each of LPP, the Reporting Person and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| June 23, 2025 Filed Jun 26, 2025 00:07 UTC |
ENRIGHT PATRICK GDirector
|
PurchaseClass A Common Stock | 139,595 | $20.87 | $2,913,110.34 |
DisclosureSEC source: 0000950170-25-090110 · ownership.xml · nonDerivative · entry 2 ENRIGHT PATRICK G · CIK 0001253886 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 3,569,522 F1 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $20.43 to $21.05, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote 1 to this Form 4. F3 · ownership.nature: These shares are held by Longitude Venture Partners IV, L.P ("LVPIV"). Longitude Capital Partners IV, LLC ("LCPIV") is the general partner of LVPIV and may be deemed to have voting and dispositive power over the shares held by LVPIV. The Reporting Person and Ms. Tammenoms Bakker are managing members of LCPIV and may be deemed to share voting and dispositive power with respect to the shares held by LVPIV. Each of LCPIV, the Reporting Person and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| June 23, 2025 Filed Jun 26, 2025 00:07 UTC |
ENRIGHT PATRICK GDirector
|
PurchaseClass A Common Stock | 69,798 | $20.87 | $1,456,565.60 |
DisclosureSEC source: 0000950170-25-090110 · ownership.xml · nonDerivative · entry 1 ENRIGHT PATRICK G · CIK 0001253886 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,784,083 F1 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $20.43 to $21.05, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote 1 to this Form 4. F2 · ownership.nature: These shares are held by Longitude Prime Fund, L.P. ("LPF"). Longitude Prime Partners, LLC ("LPP") is the general partner of LPF and may be deemed to have voting and investment power over the securities held by LPF. The Reporting Person and Juliet Tammenoms Bakker are the managing members of LPP and may be deemed to share voting and dispositive power over the shares held by LPF. Each of LPP, the Reporting Person and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| May 14, 2025 Filed May 16, 2025 20:08 UTC |
Hall KimballDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001415889-25-013415 · form4-05162025_080530.xml · derivative · entry 1 Hall Kimball · CIK 0001897965 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Class A Common Stock · 14,000 shares Expires 2035-05-13 F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control. Read SEC document |
| May 14, 2025 Filed May 16, 2025 20:10 UTC |
SEIDENBERG BETH CDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001415889-25-013417 · form4-05162025_080516.xml · derivative · entry 1 SEIDENBERG BETH C · CIK 0001184592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Class A Common Stock · 14,000 shares Expires 2035-05-13 F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control. Read SEC document |
| May 14, 2025 Filed May 16, 2025 20:11 UTC |
MORRISSEY MICHAELDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001415889-25-013419 · form4-05162025_080509.xml · derivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Class A Common Stock · 14,000 shares Expires 2035-05-13 F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control. Read SEC document |
| May 14, 2025 Filed May 16, 2025 20:13 UTC |
ENRIGHT PATRICK GDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001415889-25-013421 · form4-05162025_080556.xml · derivative · entry 1 ENRIGHT PATRICK G · CIK 0001253886 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Class A Common Stock · 14,000 shares Expires 2035-05-13 F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control. Read SEC document |
| May 14, 2025 Filed May 16, 2025 20:06 UTC |
Morrison Scott WDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001415889-25-013412 · form4-05162025_080528.xml · derivative · entry 1 Morrison Scott W · CIK 0001662426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Class A Common Stock · 14,000 shares Expires 2035-05-13 F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control. Read SEC document |
| May 14, 2025 Filed May 16, 2025 16:13 UTC |
Katabi MahaDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001415889-25-013423 · form4-05162025_080547.xml · derivative · entry 1 Katabi Maha · CIK 0001720685 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Class A Common Stock · 14,000 shares Expires 2035-05-13 F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control. Read SEC document |
| May 14, 2025 Filed May 16, 2025 20:05 UTC |
Cheng AndrewDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001415889-25-013408 · form4-05162025_080509.xml · derivative · entry 1 Cheng Andrew · CIK 0001778307 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Class A Common Stock · 14,000 shares Expires 2035-05-13 F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control. Read SEC document |
| May 14, 2025 Filed May 16, 2025 20:12 UTC |
Oliger Christy J.Director
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001415889-25-013420 · form4-05162025_080502.xml · derivative · entry 1 Oliger Christy J. · CIK 0001822092 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Class A Common Stock · 14,000 shares Expires 2035-05-13 F1 · derivative.exercise_date: The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control. Read SEC document |
| February 26, 2025 Filed Feb 27, 2025 21:05 UTC |
Fordyce MarshallDirector · PRESIDENT AND CEO
|
SaleClass A Common Stock | 1,100 | $28.32 | $31,150.13 |
DisclosureSEC source: 0001415889-25-005841 · form4-02272025_090225.xml · nonDerivative · entry 3 Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 204,665 F5 · kind: The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 23, 2024. F7 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $28.25 to $28.42, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 26, 2025 Filed Feb 27, 2025 21:05 UTC |
Fordyce MarshallDirector · PRESIDENT AND CEO
|
SaleClass A Common Stock | 7,975 | $27.55 | $219,731.99 |
DisclosureSEC source: 0001415889-25-005841 · form4-02272025_090225.xml · nonDerivative · entry 2 Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 205,765 F5 · kind: The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 23, 2024. F6 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $27.24 to $28.21, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 21, 2025 Filed Feb 27, 2025 21:05 UTC |
Fordyce MarshallDirector · PRESIDENT AND CEO
|
SaleClass A Common Stock | 10,613 | $27.89 | $296,031.59 |
DisclosureSEC source: 0001415889-25-005841 · form4-02272025_090225.xml · nonDerivative · entry 1 Fordyce Marshall · CIK 0001859453 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 213,740 F1 · date: The trading order for shares sold to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) of all participants for the Issuer, including the Reporting Person, occurred over a period of three (3) business days, beginning on February 21, 2025 and ending on February 25, 2025. F2 · deemedExecutionDate: Pursuant to Rule 16a-3(g)(2) and (3). F3 · kind: Shares sold to cover tax withholding obligations associated with the vesting of RSUs pursuant to an election intended to satisfy the conditions of Rule 10b5-1(c) made by the Reporting Person on August 26, 2022. F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $26.37 to $29.80, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 16:10 UTC |
Brenner RobertChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 53,800 | $0.00 Strike: $29.18 | $0.00 |
DisclosureSEC source: 0001415889-25-004847 · form4-02202025_090217.xml · derivative · entry 2 Brenner Robert · CIK 0002006910 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,800 Underlying: Class A Common Stock · 53,800 shares Expires 2035-02-17 F3 · derivative.exercise_date: 1/48 of the shares subject to the stock option will vest and become exercisable on March 18, 2025, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.